abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology, specifically to production of subunit vaccines against Mycoplasma hyorhinis, and can be used in medicine to prevent a disease caused by Mycoplasma hyorhinis infection, selected from peritonitis, pleurisy, pericarditis and joint swelling. Disclosed is a vaccine composition based on a combination of proteins XylF, DnaK and P72 in combination with an adjuvant. For recombinant production of active vaccine in prokaryotic expression system expression vector is proposed, as well as a method of producing which enables to obtain an active principle of the composition in form of a soluble protein.EFFECT: invention provides achieving a strong immune response against Mycoplasma hyorhinis.10 cl, 2 dwg, 7 tbl, 3 ex |